Browse the evidence

Prolonged sleep deficiency (short duration or disturbance) causes chronic, systemic low-grade inflammation, which is associated with increased risk of inflammatory diseases such as diabetes, atherosclerosis, and neurodegeneration.

Prioritize consistent, sufficient sleep duration and quality. Chronic sleep loss is not just about feeling tired; it actively drives systemic inflammation, increasing your risk for diabetes, heart disease, and neurodegeneration. Treat sleep as a non-negotiable pillar of immune health, equal in importance to nutrition and exercise.

Adequate sleep enhances host defense by improving infection outcomes and vaccination responses, mediated by the induction of a hormonal constellation that supports immune functions.

Ensure you get adequate sleep, especially around the time of vaccination or when you suspect an infection. Sleep actively boosts your immune response, improving vaccine efficacy and helping your body fight off pathogens more effectively. Prioritizing sleep is a proactive strategy for immune resilience.

Supplementation with EPA and DHA (2.7 g/day EPA) reduces the production of pro-inflammatory eicosanoids (like PGE2) and cytokines (TNF-alpha, IL-1beta) by altering cell membrane phospholipid composition and inhibiting NF-kB activation.

To reduce inflammation, standard fish oil doses may be insufficient. Research suggests a threshold of approximately 2.7 grams of EPA per day is needed to significantly lower inflammatory markers like PGE2. This is higher than typical dietary intake. For conditions like RA, this dosage has shown clinical benefits like reduced stiffness and pain.

High-volume, intense exercise training and competition are associated with transient immune dysfunction and an increased risk of upper respiratory tract infections (URTI).

If you are training for a marathon or competing in endurance events, be aware that your risk of getting sick spikes in the days following the event. Prioritize recovery, sleep, and nutrition immediately after heavy exertion to mitigate this risk.

Daily supplementation of 400 IU of vitamin D prevents nutritional rickets in children, whereas 800 IU of vitamin D combined with appropriate calcium intake reduces osteoporotic fracture risk in vitamin D-deficient or institutionalized elderly subjects.

If you are an older adult living in care or have low vitamin D levels, take 800 IU of Vitamin D3 daily along with adequate calcium to help protect your bones from fractures. For children, 400 IU daily is the standard to prevent rickets. Do not assume mega-doses work better; very high single doses may actually increase fracture risk.

Exercise-induced skeletal muscle secretion of IL-6 mediates metabolic crosstalk, specifically enhancing glucose uptake and fatty acid oxidation within muscle and stimulating hepatic glucose production during exercise.

Regular exercise triggers your muscles to release IL-6, which helps your muscles use more glucose and fat for energy and signals your liver to release glucose when needed. This hormonal communication is a key reason why exercise improves metabolic health beyond just burning calories.

Exercise-induced secretion of myokines like IL-6, BDNF, Cathepsin B, and Irisin mediates muscle-brain crosstalk, promoting hippocampal neurogenesis, cognitive function, and potentially protecting against neurodegenerative diseases.

Exercise helps your brain by releasing factors like BDNF and Cathepsin B that support new neuron growth and cognitive function. This is particularly important for maintaining mental sharpness and potentially reducing the risk of dementia as you age.

Exercise-induced myokines, particularly IL-6, mediate muscle-adipose crosstalk by promoting lipolysis, fat oxidation, and potentially the browning of white adipose tissue, thereby reducing visceral adiposity.

Exercise helps you lose fat by triggering your muscles to release IL-6, which directly stimulates fat breakdown and oxidation. This hormonal signal is crucial for reducing visceral fat, especially when combined with a healthy diet.

Genetic variants near the NKX6.3 gene (specifically rs6981587) are associated with the degree of weight loss in response to low-caloric diet interventions, with the major C allele linked to decreased weight loss efficacy.

If you are struggling with weight loss despite strict adherence to a low-calorie diet, genetic factors near the NKX6.3 gene may be influencing your response. This is not a failure of willpower but a biological variance. Consider genetic counseling or personalized nutrition approaches that account for this variability, rather than assuming standard protocols will work identically for everyone.

Autophagy is a double-edged sword in muscle health: it is essential for removing damaged components and preventing degeneration, but its hyperactivation contributes to muscle loss in pathological conditions.

Autophagy is your muscle's recycling system. It is essential for removing damaged parts and maintaining health. However, in states of severe stress or disease, this system can become overactive and break down muscle faster than it can be replaced. Balancing this system is key to maintaining muscle mass.

Non-fasting (postprandial) triglyceride levels are a significant and often neglected risk factor for premature ASCVD, as the postprandial state is the norm for most of the day and involves the accumulation of atherogenic remnant particles.

Your heart disease risk is not just determined by how you feel after an overnight fast. The hours after you eat, when fat particles are circulating, contribute significantly to plaque buildup. If you have high triglycerides, your non-fasting levels are likely even higher and more dangerous.

GLP-1 receptor agonists promote long-term weight loss by reducing appetite and food intake, primarily through effects on the hypothalamus.

GLP-1 receptor agonists help with weight loss by reducing hunger and the amount of food consumed. This effect is mediated by the brain's hypothalamus. Patients may experience reduced appetite as a primary mechanism for weight management.

High dietary fiber intake (specifically insoluble cereal fiber and whole grains) is associated with improved insulin sensitivity and a reduced risk of type 2 diabetes, primarily through gut microbiota-mediated mechanisms such as short-chain fatty acid (SCFA) production.

Prioritize insoluble fiber sources like whole grains and vegetables to support insulin sensitivity. While soluble fiber is beneficial, current evidence suggests insoluble fiber from whole grains may be more critical for preventing type 2 diabetes. Aim to increase intake significantly above current Western averages (often 18-24g/day) toward the recommended 30-35g/day for men and 25-32g/day for women.

Age-related skeletal muscle loss (sarcopenia) is fundamentally driven by 'anabolic resistance,' a blunted muscle protein synthesis response to nutritional and exercise stimuli, compounded by reduced physical activity.

As you age, your muscles become less sensitive to protein and exercise. To maintain muscle, you likely need to consume more protein per meal and engage in resistance training, as your body's natural response to these stimuli is blunted compared to when you were younger.

Fermentation reduces the glycemic index (GI) of fermented foods through the production of organic acids (lactic, acetic, propionic) which suppress starch-hydrolyzing enzymes and delay gastric emptying.

If you are managing blood sugar, consider incorporating fermented grain products like sourdough bread. The organic acids produced during fermentation can help blunt post-meal glucose spikes compared to unfermented breads.

Initiation of sodium-glucose cotransporter-2 inhibitors (SGLT-2i) in patients with type 2 diabetes is associated with a significantly lower risk of hospitalization for heart failure and all-cause death compared to other glucose-lowering drugs, representing a class-wide benefit.

For patients with Type 2 Diabetes, starting an SGLT-2 inhibitor (such as canagliflozin, dapagliflozin, or empagliflozin) is associated with a significantly lower risk of heart failure hospitalization and death compared to other common diabetes medications. This benefit appears to apply to the entire class of drugs, not just one specific brand, and extends to patients without established heart disease. Patients should discuss these cardiovascular benefits with their healthcare provider when selecting a treatment plan.

Pre-sleep ingestion of 30–40 g of casein protein increases overnight muscle protein synthesis and metabolic rate without influencing lipolysis.

If you want to support muscle growth overnight, eat 30–40 grams of casein protein (like cottage cheese or a casein shake) right before bed. It boosts muscle repair and metabolism without hindering fat loss.

Exogenous advanced glycation end products (AGEs) from heat-processed foods contribute significantly to systemic AGE accumulation, promoting oxidative stress, inflammation, and insulin resistance in type 2 diabetes.

Limit high-heat cooking methods like grilling, frying, and baking. Opt for moist-heat cooking (steaming, boiling, poaching) to reduce dietary AGE intake, which may help lower systemic inflammation and improve insulin sensitivity in type 2 diabetes.

Prolonging the nightly fasting interval (≥11-13 hours) is associated with reduced odds of elevated HbA1c, lower inflammatory markers, and reduced breast cancer recurrence risk.

Aim for at least 13 hours of fasting between dinner and breakfast. This simple timing strategy is associated with lower inflammation and potentially better long-term health outcomes, including reduced cancer recurrence risk.

SSB consumption increases the risk of type 2 diabetes (T2DM) and cardiovascular disease (CVD) independently of, and mediated by, weight gain.

Even if you are not overweight, limiting SSBs is important for preventing type 2 diabetes and heart disease. The sugars in these drinks can negatively affect your metabolism, insulin response, and blood lipids independently of your weight.

Elevated circulating levels of branched-chain amino acids (BCAAs) are associated with an increased risk of insulin resistance (IR) and type 2 diabetes mellitus (T2DM), acting as biomarkers for these metabolic conditions.

If you are concerned about insulin resistance or type 2 diabetes, simply taking BCAA supplements may not help and could potentially reflect or exacerbate underlying metabolic issues. Focus on overall metabolic health, including diet quality and physical activity, rather than isolated BCAA supplementation, especially if you have obesity or pre-diabetic conditions.

BCAAs, particularly leucine, stimulate muscle protein synthesis via the mTOR signaling pathway, but this effect may be blunted or associated with insulin resistance if circulating BCAA levels are chronically elevated.

BCAAs, especially leucine, do stimulate muscle protein synthesis through the mTOR pathway. However, if you have insulin resistance or obesity, chronically high BCAA levels might contribute to metabolic issues. Focus on a balanced diet and exercise rather than relying solely on BCAA supplements for muscle growth.

Intermittent fasting improves cardiometabolic risk factors, including insulin resistance, dyslipidemia, and inflammation, by triggering the metabolic switch.

Fasting can help fix metabolic issues like high blood sugar and bad cholesterol. By not eating for 12+ hours, your body switches to burning fat, which reduces inflammation and improves how your body handles insulin.

SGLT2 inhibitors (e.g., Dapagliflozin, Ipragliflozin) and GLP-1 agonists (e.g., Exenatide) improve endothelial function in T2DM patients, independent of or beyond their glucose-lowering effects.

If you have T2DM, ask your doctor about SGLT2 inhibitors or GLP-1 agonists. These drugs not only lower blood sugar but also directly protect your blood vessels and heart, improving how your arteries expand and contract.